Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

Aslan Fred sold 62,178 Artiva Biotherapeutics, Inc. shares (Form 4)

Traded Nov 2, 2026 · Filed Nov 3, 2026

On Nov 2, 2026, Aslan Fred (Director, Chief Executive Officer) sold 62,178 Artiva Biotherapeutics, Inc. shares at US$4.18 for US$260K, leaving 1,457,428 shares. Filed Nov 3, 2026 (Form 4).

Sold
62,178 shares
Price
US$4.18
Value
US$260K
Holding after
1,457,428 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 2, 2026Common StockSale62,178US$4.181,457,428Direct

Source

Download original · View original at SEC

Related